QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

GENTICKER

Gen Digital Inc.

VERY BULLISH stock

Congress has disclosed 4 buys and 4 sells of GEN (Gen Digital Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

4
Buy
4
Sell
+0
Net
5
Active politicians

Round-trip watch Still on the books

Members who disclosed buying GEN and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Alan Armstrong 2026-03-27 $18.16 $29.13 +60.4% in profit
Gilbert Cisneros 2026-04-14 $18.73 $29.13 +55.6% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2027 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Technology. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
14.33
▼ cheaper than Technology (median 33.7)
how it's calculated
P/E = price ÷ earnings per share
$29.13 ÷ $2.03 = 14.33
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
6.31
≈ in line with Technology (median 6.2)
how it's calculated
P/B = price ÷ book value per share
$29.13 ÷ $4.62 = 6.31
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
9.1
▼ cheaper than Technology (median 21.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($17.3B + $7.1B net debt) ÷ $2.7B = $24.4B ÷ $2.7B = 9.1
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

Legislation Related Legislation

Recent bills in this stock's sector (Technology). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.

BillTitlePolicy areaLatest action
HR 7022 Mystic Alerts Act Science, Technology, Communications 2026-10-22
S 5663 PROOF Act Science, Technology, Communications 2026-09-30
SRES 923 A resolution expressing support for the designation of October 4 through October 10, 2026, as "National 4-H Week". Science, Technology, Communications 2026-09-29
HR 10610 Stop Spam Calls Act Science, Technology, Communications 2026-09-24
HR 10594 Reliable Artificial Intelligence Research Act of 2026 Science, Technology, Communications 2026-09-24

8 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Gilbert Cisneros House BUY ◆ insider convergence · moderate Self · 150 Main Street Trust > Bank of America 2026-04-14 23 days +6.8% $1K–$15K
0.1% of NW
69.1 ↗ filing
Alan Armstrong Senate BUY ◆ insider divergence Self 2026-03-27 116 days +43.1% $1K–$15K 89.2 ↗ eFD
Julie Johnson House SELL ◆ insider divergence · moderate Joint · Merrill Lynch Long Term Growth 2025-10-22 15 days -6.5% $1K–$15K
<0.1% of NW
20.3 ↗ filing
Julie Johnson House BUY ◆ insider convergence · moderate Joint · Merrill Lynch Long Term Growth 2025-10-21 16 days -7.0% $1K–$15K
<0.1% of NW
63.0 ↗ filing
Julie Johnson House SELL ◆ insider divergence · moderate Joint · Merrill Lynch Tax Efficient Core 2025-10-21 16 days -7.0% $1K–$15K
<0.1% of NW
66.6 ↗ filing
Valerie Hoyle House SELL ◆ insider divergence · moderate Spouse · Fidelity Rollover IRA 2025-09-23 0 days 0.0% $1K–$15K
0.8% of NW
49.2 ↗ filing
Jefferson Shreve House SELL ◆ insider convergence Self · CRT - Standard Unit Trust 2025-04-07 18 days +6.5% $15K–$50K
<0.1% of NW
69.2 ↗ filing
Valerie Hoyle House BUY ◆ insider divergence Spouse · Fidelity Rollover IRA 2024-10-29 317 days +11.3% $1K–$15K
0.8% of NW
65.6 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in GEN — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

3
Congress trades with insider convergence
5
…with insider divergence
27
Insider open-market trades

Of the congressional trades in GEN, 3 coincided with corporate insiders moving the same way within 60 days, and 5 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-09-04 KO BRYAN SEUK C-suite SELL 10b5-1 $866K ↗ EDGAR
2026-08-27 Vlcek Ondrej Director SELL $6.0M ↗ EDGAR
2026-08-25 Vlcek Ondrej Director SELL $4.4M ↗ EDGAR
2026-08-21 Vlcek Ondrej Director SELL $1.4M ↗ EDGAR
2026-08-19 Vlcek Ondrej Director SELL $2.8M ↗ EDGAR
2026-08-17 Witteveen Travis Michael Other SELL $12K ↗ EDGAR
2026-08-10 Witteveen Travis Michael Other SELL $883K ↗ EDGAR
2026-06-10 Vlcek Ondrej Director SELL $2.5M ↗ EDGAR
2026-06-04 Chrystal John C Director BUY $81K ↗ EDGAR
2026-02-17 DERSE NATALIE MARIE C-suite SELL $19K ↗ EDGAR
2025-12-10 Vlcek Ondrej Director SELL $3.1M ↗ EDGAR
2025-11-13 Chrystal John C Director BUY $136K ↗ EDGAR
2025-08-13 KO BRYAN SEUK Other SELL 10b5-1 $1.3M ↗ EDGAR
2025-08-13 Chrystal John C Director BUY $321K ↗ EDGAR
2025-05-16 Denzel Nora Director SELL $910K ↗ EDGAR
2025-02-18 DERSE NATALIE MARIE C-suite SELL $27K ↗ EDGAR
2024-11-26 KO BRYAN SEUK Other SELL 10b5-1 $319K ↗ EDGAR
2024-11-26 KO BRYAN SEUK Other SELL 10b5-1 $1.2M ↗ EDGAR
2024-08-19 Pilette Vincent C-suite SELL $4.6M ↗ EDGAR
2024-05-15 Feld Peter A Director SELL $975K ↗ EDGAR
2024-05-15 Feld Peter A Director SELL $7.5M ↗ EDGAR
2024-05-14 DERSE NATALIE MARIE C-suite SELL $4.1M ↗ EDGAR
2024-05-14 Feld Peter A Director SELL $2.1M ↗ EDGAR
2024-05-14 Feld Peter A Director SELL $16.2M ↗ EDGAR
2024-02-16 DERSE NATALIE MARIE C-suite SELL $26K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-09-04 KO BRYAN SEUK C-suite 10b5-1 SELL $866K
◆ insider 2026-08-27 Vlcek Ondrej Director SELL $6.0M
◆ insider 2026-08-25 Vlcek Ondrej Director SELL $4.4M
◆ insider 2026-08-21 Vlcek Ondrej Director SELL $1.4M
◆ insider 2026-08-19 Vlcek Ondrej Director SELL $2.8M
◆ insider 2026-08-17 Witteveen Travis Michael Other SELL $12K
◆ insider 2026-08-10 Witteveen Travis Michael Other SELL $883K
◆ insider 2026-06-10 Vlcek Ondrej Director SELL $2.5M
◆ insider 2026-06-04 Chrystal John C Director BUY $81K
Congress 2026-04-14 Gilbert Cisneros BUY $1K–$15K
Congress 2026-03-27 Alan Armstrong BUY $1K–$15K
◆ insider 2026-02-17 DERSE NATALIE MARIE C-suite SELL $19K
◆ insider 2025-12-10 Vlcek Ondrej Director SELL $3.1M
◆ insider 2025-11-13 Chrystal John C Director BUY $136K
Congress 2025-10-22 Julie Johnson SELL $1K–$15K
Congress 2025-10-21 Julie Johnson BUY $1K–$15K
Congress 2025-10-21 Julie Johnson SELL $1K–$15K
Congress 2025-09-23 Valerie Hoyle SELL $1K–$15K
◆ insider 2025-08-13 KO BRYAN SEUK Other 10b5-1 SELL $1.3M
◆ insider 2025-08-13 Chrystal John C Director BUY $321K
◆ insider 2025-05-16 Denzel Nora Director SELL $910K
Congress 2025-04-07 Jefferson Shreve SELL $15K–$50K
◆ insider 2025-02-18 DERSE NATALIE MARIE C-suite SELL $27K
◆ insider 2024-11-26 KO BRYAN SEUK Other 10b5-1 SELL $319K

FAQ Common questions

How much has Congress traded GEN?

4 disclosed buys and 4 sells of GEN (Gen Digital Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade GEN?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.